# ROCKET LAB CORP (RKLB) FY2026 Q1 Balance Sheet

- Company: ROCKET LAB CORP (RKLB)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-07, accession number 0001819994-26-000028
- Page: https://plicit.ai/financials/rklb/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/rklb-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 2,819,941,000 US dollars
- **Current assets**: 1,800,362,000 US dollars
- **Non-current assets**: 1,019,579,000 US dollars
- **Liabilities**: 555,574,000 US dollars
- **Current liabilities**: 402,345,000 US dollars
- **Non-current liabilities**: 153,229,000 US dollars
- **Equity**: 2,264,367,000 US dollars
- **Cash and cash equivalents**: 1,205,499,000 US dollars
- **Inventories**: 183,146,000 US dollars
- **Marketable securities, current**: 177,852,000 US dollars
- **Prepaids and other current assets**: 83,874,000 US dollars
- **Contract assets**: 75,036,000 US dollars
- **Accounts receivable, net**: 74,955,000 US dollars
- **Property, plant and equipment, net**: 343,988,000 US dollars
- **Intangible assets, net**: 220,567,000 US dollars
- **Goodwill**: 208,738,000 US dollars
- **Marketable securities, non-current**: 93,494,000 US dollars
- **Right-of-use assets - operating leases**: 90,933,000 US dollars
- **Other non-current assets**: 41,719,000 US dollars
- **Right-of-use assets - finance leases**: 13,767,000 US dollars
- **Restricted cash**: 5,524,000 US dollars
- **Deferred income tax assets, net**: 849,000 US dollars
- **Contract liabilities**: 241,412,000 US dollars
- **Trade payables**: 63,112,000 US dollars
- **Employee benefits payable**: 40,720,000 US dollars
- **Accrued expenses**: 33,546,000 US dollars
- **Other current liabilities**: 23,555,000 US dollars
- **Non-current operating lease liabilities**: 85,517,000 US dollars
- **Convertible senior notes, net**: 36,869,000 US dollars
- **Non-current finance lease liabilities**: 14,568,000 US dollars
- **Other non-current liabilities**: 13,207,000 US dollars
- **Long-term borrowings, net**: 1,716,000 US dollars
- **Deferred income tax liabilities**: 1,352,000 US dollars
- **Additional paid-in capital**: 3,324,206,000 US dollars
- **Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 621,718,750 and 589,525,802 at March 31, 2026 and December 31, 2025, respectively; outstanding shares: 575,767,500 and 543,574,552 at March 31, 2026 and December 31, 2025, respectively**: 58,000 US dollars
- **Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 45,951,250 at March 31, 2026 and December 31, 2025**: 5,000 US dollars
- **Treasury stock, at cost; shares: 45,951,250 at March 31, 2026 and December 31, 2025**: 0 US dollars
- **Accumulated deficit**: negative 1,056,932,000 US dollars
- **Accumulated other comprehensive loss**: negative 2,970,000 US dollars
- **Gross equity (calculated)**: 3,324,269,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.